Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients

Fig. 2

Cumulative incidence of liver metastases in all patients subdivided according to absence/presence of liver steatosis, including all metastases (a) and only metastases occurring during follow-up (b). Note that in graph A, cumulative hazard curves start from the observed values of synchronous metastases, i.e. 13.0% in patients without steatosis and 18.9% in patients with steatosis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us